Research Article
BibTex RIS Cite

Year 2025, Volume: 8 Issue: 1, 14 - 19, 03.07.2025
https://doi.org/10.54994/emujpharmsci.1687706

Abstract

References

  • Bellio P, Fagnani L, Nazzicone L, Celenza G (2021). New and simplified method for drug combination studies by checkerboard assay. MethodsX 8: 101543.
  • Bravo HR, Copaja SV, Lazo W (1997). Antimicrobial activity of natural 2-benzoxazolinones and related derivatives. J Agric Food Chem 45: 3255-3257.
  • Koksal M, Gokhan N, Erdogan H, Ozalp M, Ekizoglu M (2002). Synthesis of 3-(4-substituted benzoylmethyl)-2-benzoxazolinones and screening antimicrobial activities. Il Farmaco 57(7): 535-538.
  • Ozalp M, Calis U, Gokhan N, Erdogan H (2001). Evaluation of antimicrobial activities of some 2-benzoxazolinone derivatives. FABAD J Pharm Sci 26: 169-172.
  • Siugzdaite J, Lelesius R, Grybaite B, Vaickelioniene R, Mickevicius V (2024). Synthesis and biological studies of new 2-benzoxazolinone derivatives as antibacterial agents. Appl Sci 14: 4783.
  • Verma H, Silakari O (2018). Chapter 10 - Benzoxazolinone: A scaffold with diverse pharmacological significance. Key Heterocycle Cores for Designing Multitargeting Molecules p. 343-367. Punjabi University, Patiala, India.
  • Wikler MA (2006). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard, vol. 26, p M7–A7. CLSI, Wayne, Pennsylvania.

In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin

Year 2025, Volume: 8 Issue: 1, 14 - 19, 03.07.2025
https://doi.org/10.54994/emujpharmsci.1687706

Abstract

In the present study, it was aimed to demonstrate the antibacterial and synergistic activities of 2-benzoxazolinone, a promising allelochemical, against Klebsiella pneumoniae ATCC 700603, Escherichia coli ATCC 25922, Enterococcus faecalis ATCC 29212, and Staphylococcus aureus ATCC 25923 via broth microdilution method. 2-benzoxazolinone exhibited promising antibacterial activity against all tested bacteria with 4 mg/mL against E. coli and E. faecalis, and K. pneumoniae and S. aureus 2 mg/mL against. When used in combination with ciprofloxacin, no antagonistic activity was observed. However, the combination interaction revealed indifferent activity against all tested strains. Overall, the antibacterial data obtained from the study demonstrated that 2-benzoxazolinone can further be used as a potential antibacterial agent in the treatment of bacterial infections.

References

  • Bellio P, Fagnani L, Nazzicone L, Celenza G (2021). New and simplified method for drug combination studies by checkerboard assay. MethodsX 8: 101543.
  • Bravo HR, Copaja SV, Lazo W (1997). Antimicrobial activity of natural 2-benzoxazolinones and related derivatives. J Agric Food Chem 45: 3255-3257.
  • Koksal M, Gokhan N, Erdogan H, Ozalp M, Ekizoglu M (2002). Synthesis of 3-(4-substituted benzoylmethyl)-2-benzoxazolinones and screening antimicrobial activities. Il Farmaco 57(7): 535-538.
  • Ozalp M, Calis U, Gokhan N, Erdogan H (2001). Evaluation of antimicrobial activities of some 2-benzoxazolinone derivatives. FABAD J Pharm Sci 26: 169-172.
  • Siugzdaite J, Lelesius R, Grybaite B, Vaickelioniene R, Mickevicius V (2024). Synthesis and biological studies of new 2-benzoxazolinone derivatives as antibacterial agents. Appl Sci 14: 4783.
  • Verma H, Silakari O (2018). Chapter 10 - Benzoxazolinone: A scaffold with diverse pharmacological significance. Key Heterocycle Cores for Designing Multitargeting Molecules p. 343-367. Punjabi University, Patiala, India.
  • Wikler MA (2006). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: Approved standard, vol. 26, p M7–A7. CLSI, Wayne, Pennsylvania.
There are 7 citations in total.

Details

Primary Language English
Subjects Pharmaceutical Microbiology
Journal Section Research Article
Authors

Ertuğrul Özbil

Publication Date July 3, 2025
Submission Date April 30, 2025
Acceptance Date June 19, 2025
Published in Issue Year 2025 Volume: 8 Issue: 1

Cite

APA Özbil, E. (2025). In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin. EMU Journal of Pharmaceutical Sciences, 8(1), 14-19. https://doi.org/10.54994/emujpharmsci.1687706
AMA Özbil E. In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin. EMUJPharmSci. July 2025;8(1):14-19. doi:10.54994/emujpharmsci.1687706
Chicago Özbil, Ertuğrul. “In Vitro Evaluation of Antibacterial Activity 2-Benzoxazolinone and Its Combination Interaction With Ciprofloxacin”. EMU Journal of Pharmaceutical Sciences 8, no. 1 (July 2025): 14-19. https://doi.org/10.54994/emujpharmsci.1687706.
EndNote Özbil E (July 1, 2025) In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin. EMU Journal of Pharmaceutical Sciences 8 1 14–19.
IEEE E. Özbil, “In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin”, EMUJPharmSci, vol. 8, no. 1, pp. 14–19, 2025, doi: 10.54994/emujpharmsci.1687706.
ISNAD Özbil, Ertuğrul. “In Vitro Evaluation of Antibacterial Activity 2-Benzoxazolinone and Its Combination Interaction With Ciprofloxacin”. EMU Journal of Pharmaceutical Sciences 8/1 (July2025), 14-19. https://doi.org/10.54994/emujpharmsci.1687706.
JAMA Özbil E. In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin. EMUJPharmSci. 2025;8:14–19.
MLA Özbil, Ertuğrul. “In Vitro Evaluation of Antibacterial Activity 2-Benzoxazolinone and Its Combination Interaction With Ciprofloxacin”. EMU Journal of Pharmaceutical Sciences, vol. 8, no. 1, 2025, pp. 14-19, doi:10.54994/emujpharmsci.1687706.
Vancouver Özbil E. In vitro Evaluation of Antibacterial Activity 2-benzoxazolinone and Its Combination Interaction with Ciprofloxacin. EMUJPharmSci. 2025;8(1):14-9.